Odense University Hospital

T-cell therapy developer, Cbio A/S Unveils 2023 Annual Report Amid Clinical Trial Preparations, Signaling Major Shift to Clinical Stage with DKK40M Financing Secured

Retrieved on: 
Friday, April 12, 2024

SØBORG, Denmark, April 12, 2024 (GLOBE NEWSWIRE) -- Cbio A/S – Pioneering Next-Gen T-Cell Therapies for Solid Tumors, Unveils 2023 Financial Results and Company Updates.

Key Points: 
  • SØBORG, Denmark, April 12, 2024 (GLOBE NEWSWIRE) -- Cbio A/S – Pioneering Next-Gen T-Cell Therapies for Solid Tumors, Unveils 2023 Financial Results and Company Updates.
  • Ulrik Cordes, Founder & CEO of Cbio, stated: “2023 was another great year for Cbio.
  • We finalized the preclinical development of our lead T-cell therapy asset, novoleucel and made considerable progress in preparing for our upcoming phase I/II clinical trial at Karolinska, where we will treat 20 patients with late-stage cervical cancer.
  • Ulrik Cordes continues: “Our top priority for 2024 is to start our first clinical trial, thereby reaching a major value inflection point.

BD and Health Care Consortium in Denmark Find Success in Medical Waste Recycling Study

Retrieved on: 
Monday, March 18, 2024

The study shows that these used tubes, which are made from high-quality polyethylene terephthalate (PET) plastic, can be cleaned, shredded and molded into other types of new articles.

Key Points: 
  • The study shows that these used tubes, which are made from high-quality polyethylene terephthalate (PET) plastic, can be cleaned, shredded and molded into other types of new articles.
  • "Single-use plastic revolutionized health care, but we know there are environmental considerations that come with this critical innovation," said Amit Limaye, director of the BD Sustainable Medical Technology Institute.
  • Used blood collection tubes are considered biohazardous and regulated medical waste, and in Denmark, they are currently disposed through incineration.
  • To learn more about this study, visit the website of Health Innovation Centre of Southern Denmark, and to learn more about BD's commitments to net zero emissions, visit the BD newsroom .

Lunit Presents Seven Study Results at ECR 2024: Showcasing AI's Robust Performance in Diverse Clinical Settings

Retrieved on: 
Wednesday, February 28, 2024

SEOUL, South Korea, Feb. 28, 2024 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today announced the presentation of seven studies at the European Congress of Radiology (ECR) 2024, to be held in Vienna, Austria, from February 28 to March 3. Four will be presented through oral presentations and three as E-posters.

Key Points: 
  • Four out of seven AI products, including Lunit INSIGHT CXR, showed superior performance compared to human readers.
  • Lunit invites booth visitors at ECR 2024 to explore detailed information on the project and discuss potential future collaborations.
  • "We are proud to present our latest research findings at this year's ECR, demonstrating the robust performance and versatility of our Lunit INSIGHT suite in various clinical settings and scenarios.
  • Join Lunit at booth AI-15 in the EXPO X1 hall to witness how the Lunit INSIGHT suite is shaping the future of radiology across the globe.

Health Care Collaboration in Denmark Aims to Reduce Medical Waste

Retrieved on: 
Monday, May 8, 2023

COPENHAGEN, Denmark, May 8, 2023 /PRNewswire/ -- A new health care sector collaboration in Denmark will evaluate the feasibility of recycling used blood collection tubes to reduce medical waste as part of the participants' sustainability goals and Denmark's Climate Action Strategy.

Key Points: 
  • COPENHAGEN, Denmark, May 8, 2023 /PRNewswire/ -- A new health care sector collaboration in Denmark will evaluate the feasibility of recycling used blood collection tubes to reduce medical waste as part of the participants' sustainability goals and Denmark's Climate Action Strategy.
  • The pilot program is a collaboration among BD (Becton, Dickinson and Company) (NYSE:BDX), Odense University Hospital, the Health Innovation Centre of Southern Denmark, Danish Technological Institute, and GMAF Circular Medico/EcoFitt that will occur at the Odense University Hospital in Odense, Denmark.
  • This partnership and program are a great example of like-minded stakeholders coming together to drive progress toward a greener, more sustainable health care system, because success cannot be accomplished by any one stakeholder alone."
  • Used blood collection tubes are often considered a biohazardous and regulated medical waste, and in Denmark, they are currently disposed via incineration.

UVD Robots Joins Ecolab’s Global Infection Prevention Offerings to Fight Hospital Acquired Infections

Retrieved on: 
Tuesday, January 25, 2022

(Photo: Business Wire)

Key Points: 
  • (Photo: Business Wire)
    Further fueling the demand is the rise in hospital acquired infections (HAIs) that globally cause more fatalities due to the increase in antibiotic resistance from even simple infections.
  • Ecolab has expanded its global portfolio of infection prevention solutions to include UVD Robots in its offerings for healthcare customers, including care hospitals, in-patient and out-patient clinics, ambulatory surgical facilities, and rehabilitation clinics and other care facilities.
  • Per Juul Nielsen, CEO of UVD Robots, sees the new collaboration with Ecolab as a tremendous validation of the efficiency of UVD Robots autonomous solution.
  • Ecolab is the global leader in water, hygiene and infection prevention solutions and services that protect people and vital resources.